Alshogran Osama Y, Altawalbeh Shoroq M, Khalil Amani A
Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Arch Psychiatr Nurs. 2022 Dec;41:208-213. doi: 10.1016/j.apnu.2022.08.004. Epub 2022 Aug 28.
INTRODUCTION: Psychiatric illness is prevalent among hemodialysis (HD) patients. This study compared the assessment of anxiety and depressive symptoms among HD patients using two self-administered scales; hospital anxiety and depression scale (HADS) and brief symptom inventory (BSI). METHODS: A cross-sectional study was conducted among a convenience sample of HD patients (n = 352) from different dialysis centers in Jordan. Patients were interviewed in dialysis units, and demographics, clinical status, disease, and dialysis history data were collected. Symptoms of anxiety (HADS-A ≥ 8 and BSI-A ≥ 0.82) and depression (HADS-D ≥ 8 and BSI-D ≥ 0.82) were also measured. RESULTS: The mean age of participants was 52.2 ± 15.6 years. The majority had been receiving HD three times daily and for >2 years. A significant moderate-strong correlation was observed between HADS-A and BSI-A (r = 0.753, p < 0.0001) as well as HADS-D and BSI-D (r = 0.588, p < 0.0001). Anxiety prevalence was 43.7 % using HADS-A ≥ 8 and 80.7 % using BSI-A ≥ 0.82, while depression prevalence was 53.1 % using HADS-D ≥ 8 and 51.7 % using BSI-D ≥ 0.82. When HADS was used as a standard, the operating characteristics reveal that a higher cut-off for BSI-A is recommended (≥1.58) for better anxiety screening. DISCUSSION: Specific and suitable cut-off points need to be further explored and validated for HADS and BSI scales among patients undergoing dialysis.
引言:精神疾病在血液透析(HD)患者中很常见。本研究比较了使用两种自评量表(医院焦虑抑郁量表(HADS)和简明症状量表(BSI))对HD患者焦虑和抑郁症状的评估。 方法:对来自约旦不同透析中心的HD患者(n = 352)进行便利抽样的横断面研究。在透析单元对患者进行访谈,并收集人口统计学、临床状况、疾病和透析史数据。还测量了焦虑症状(HADS-A≥8且BSI-A≥0.82)和抑郁症状(HADS-D≥8且BSI-D≥0.82)。 结果:参与者的平均年龄为52.2±15.6岁。大多数人每天接受3次HD治疗且治疗时间超过2年。观察到HADS-A与BSI-A之间存在显著的中度-强相关性(r = 0.753,p < 0.0001)以及HADS-D与BSI-D之间存在显著的中度-强相关性(r = 0.588,p < 0.0001)。使用HADS-A≥8时焦虑患病率为43.7%,使用BSI-A≥0.82时为80.7%,而使用HADS-D≥8时抑郁患病率为53.1%,使用BSI-D≥0.82时为51.7%。以HADS作为标准时,操作特征表明,为了更好地筛查焦虑,建议对BSI-A采用更高的临界值(≥1.58)。 讨论:对于接受透析的患者,需要进一步探索和验证HADS和BSI量表的特定且合适的临界值。
Arch Psychiatr Nurs. 2022-12
Support Care Cancer. 2020-8
Br J Dermatol. 2019-3-5
Soc Psychiatry Psychiatr Epidemiol. 2011-2-4
Neurobiol Stress. 2025-6-10
Medicine (Baltimore). 2024-9-27